Cross-sectional survey on bnt162b2 mrna covid-19 vaccine serious adverse events in children 5 to 11 years of age: a monocentric experience

HIGHLIGHTS

• who: Silvia Bloise et al. from the This was a prospective, cross-sectional study conducted by the Pediatric Unit of Santa Maria Goretti Hospital, in Latina-Sapienza University of Rome (Polo Pontino) from , December , to , January The Institutional Review Board of the Maternal and Child Health Department of the Local Health Authority of Latina approved the study protocol. This report follows the STROBE reporting guideline for cross-sectional studies. We included all children aged, years undergoing first dose of vaccination with BNT162b, mRNA , vaccine between December , and, . The exclusion criterion was previous SARS-Co, infection within three . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.